Table 2 Latency periods, gestational age at delivery, mode of delivery, recurrent uterine contraction and pregnancy outcomes
Dydrogesterone group (n = 24) | Placebo group (n = 24) | p value | |
|---|---|---|---|
Latency period(days) | 27.5 (12.5, 37.8) | 34 (11, 48) | 0.448 |
GA at delivery | 35.4 ± 2.8 | 36.2 ± 3.0 | 0.392 |
GA at delivery < 34 week | 7 (29.2 %) | 5 (20.8 %) | 0.504 |
GA at delivery < 37 week | 16 (66.7 %) | 9 (37.5 %) | 0.082 |
Mode of delivery | 0.382 | ||
Vaginal delivery | 15 (62.5 %) | 12 (50 %) | |
Cesarean delivery | 9 (37.5 %) | 12 (50 %) | |
Time to recurrent uterine contraction (days) | 30.6 ± 12.3 | 13.7 ± 5.0 | 0.01 |
Pregnancy complication | 3 (12.5 %) | 1 (4.2 %) | 0.608 |